Loading clinical trials...
Loading clinical trials...
This is a Phase 1 dose escalation study to determine the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary anti-tumor activity of BMS-754807 in patients with advanced or metasta...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bristol-Myers Squibb
NCT07287098 · Breast Neoplasms
NCT06659341 · Advanced Solid Tumors Harboring KRAS G12C Mutation
NCT07060989 · Advanced Solid Tumors
NCT06663319 · Colorectal Neoplasms, Gastrointestinal Neoplasms
NCT07169851 · Nausea, Vomiting, and more
Local Institution
East Melbourne, Victoria
Local Institution
Footscray, Victoria
Local Institution
Heidelberg, Victoria
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions